{"retracted":false,"update":{"timestamp":1411171200000,"doi":"10.1007/s10637-014-0162-x","type":"correction"},"doi":"10.1007/s10637-014-0065-x","journal":"Investigational New Drugs","publisher":"Springer Nature","title":"Erratum to: Effect of simvastatin plus cetuximab/irinotecan for KRAS mutant colorectal cancer and predictive value of the RAS signature for treatment response to cetuximab"}
